Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03154541 · ClinicalTrials.gov registry record · Phase 1
SynRinse Irrigation Pilot (SIP) Trial
A Phase 1 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT03154541 is a Phase 1 study that has completed, run by University of Washington. The registered enrollment target is 30 participants.
The verdict
NCT03154541, a Phase 1 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
Assess if the use of SYNRINSE can improve short-term subjective and objective outcome measures after one week in patients with active Chronic Rhinosinusitis (CRS) who have had prior sinus surgery.
Interventions
- DRUG Synrinse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-06-06 |
| Est. Completion | 2018-05-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03154541
The ClinicalTrials.gov registry entry for NCT03154541 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Synrinse is the first listed.
NCT03154541 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03154541 about?
NCT03154541 is a clinical study titled "SynRinse Irrigation Pilot (SIP) Trial". Assess if the use of SYNRINSE can improve short-term subjective and objective outcome measures after one week in patients with active Chronic Rhinosinusitis (CRS) who have had prior sinus surgery.
What is the current status of trial NCT03154541?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2017-06-06. Estimated completion is 2018-05-30.
What interventions are being tested in trial NCT03154541?
The interventions under investigation include: Synrinse (DRUG).
Who is sponsoring clinical trial NCT03154541?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.